Compare BKNG & GSK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | BKNG | GSK |
|---|---|---|
| Founded | 1997 | 1715 |
| Country | United States | United Kingdom |
| Employees | N/A | 66841 |
| Industry | Transportation Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 139.8B | 108.7B |
| IPO Year | 1998 | N/A |
| Metric | BKNG | GSK |
|---|---|---|
| Price | $174.51 | $52.23 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 32 | 2 |
| Target Price | ★ $228.92 | N/A |
| AVG Volume (30 Days) | ★ 6.8M | 3.6M |
| Earning Date | 04-28-2026 | 04-29-2026 |
| Dividend Yield | 0.97% | ★ 3.40% |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 1.36 | N/A |
| Revenue | ★ $26,917,000,000.00 | N/A |
| Revenue This Year | $13.43 | $6.99 |
| Revenue Next Year | $8.50 | $4.19 |
| P/E Ratio | $121.28 | ★ $32.75 |
| Revenue Growth | ★ 13.39 | N/A |
| 52 Week Low | $150.14 | $35.45 |
| 52 Week High | $5,837.03 | $61.70 |
| Indicator | BKNG | GSK |
|---|---|---|
| Relative Strength Index (RSI) | 20.33 | 54.48 |
| Support Level | $166.25 | $51.55 |
| Resistance Level | $193.92 | $59.97 |
| Average True Range (ATR) | 5.60 | 0.76 |
| MACD | 39.72 | 0.39 |
| Stochastic Oscillator | 79.82 | 77.77 |
Booking is the world's largest online travel agency by sales, offering booking and payment services for hotel and alternative accommodation rooms, airlines, rental cars, restaurants, cruises, experiences, and other vacation packages. The company operates several branded travel booking sites, including Booking.com, Agoda, OpenTable, Rentalcars.com, and Kayak. Transaction fees for online bookings account for the bulk of revenue and profits.
In the pharmaceutical industry, GSK ranks as one of the largest firms by total sales. The company wields its might across several therapeutic classes, including respiratory, antiviral, and vaccines, and has been growing its presence in oncology and immunology, as well. GSK uses joint ventures to gain additional scale in certain markets like HIV.